Interleukin-1 family members are enhanced in psoriasis and suppressed by vitamin D and retinoic acid

Arch Dermatol Res. 2013 Apr;305(3):255-62. doi: 10.1007/s00403-013-1327-8. Epub 2013 Feb 24.

Abstract

Interleukin (IL)-1 family comprise 11 members that play an important role in immune regulation and inflammatory process. Retinoids exert complex effects on the immune system, having anti-inflammatory effects in chronic dermatological diseases. Vitamin D (vitD) and analogs have been shown to suppress TNF-α-induced IL-1α in human keratinocytes (KCs). In the present study, we investigated IL-1 family members in psoriasis and the effects of vitD and retinoic acid (RA) on these members. We analyzed IL-1 family members gene expression in psoriatic skin and in ex vivo skin organ culture exposed to TNF-α, IL-17 or broadband UVB; afterwards, treatment with vitD or RA was performed and IL-1 family members mRNA was evaluated. Similarly, KCs were stimulated with IL-17 and subsequently treated with vitD. IL-1 family members were enhanced in psoriatic skin and in ex vivo skin organ cultures after pro-inflammatory stimuli (TNF-α, IL-17 and UVB). RA and vitD were able to suppress this enhancement.

MeSH terms

  • Bone Density Conservation Agents / pharmacology
  • Cells, Cultured
  • Gene Expression
  • Humans
  • Inflammation / metabolism
  • Interleukin-1 / genetics
  • Interleukin-1 / metabolism*
  • Interleukin-17 / pharmacology
  • Keratinocytes / drug effects
  • Keratinocytes / metabolism
  • Keratolytic Agents / pharmacology
  • Organ Culture Techniques
  • Psoriasis / genetics
  • Psoriasis / metabolism*
  • RNA, Messenger / analysis
  • Skin / metabolism
  • Tretinoin / pharmacology*
  • Tumor Necrosis Factor-alpha / pharmacology
  • Ultraviolet Rays / adverse effects
  • Vitamin D / pharmacology*

Substances

  • Bone Density Conservation Agents
  • Interleukin-1
  • Interleukin-17
  • Keratolytic Agents
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Vitamin D
  • Tretinoin